Kinetics of serological responses in influenza A(H7N9)-infected patients correlate with clinical outcome in China, 2013.
about
A new reassortment of influenza A (H7N9) virus causing human infection in Beijing, 2014Pandemic (H1N1) 2009 Influenza Virus Infection in A Survivor Who Has Recovered from Severe H7N9 Virus Infection, China.Fc functional antibodies in humans with severe H7N9 and seasonal influenzaSeroprevalence to avian influenza A(H7N9) virus among poultry workers and the general population in southern China: a longitudinal studyClinical, virological and immunological features from patients infected with re-emergent avian-origin human H7N9 influenza disease of varying severity in Guangdong provinceRecovery from severe H7N9 disease is associated with diverse response mechanisms dominated by CD8⁺ T cells.Population seroprevalence of antibody to influenza A(H7N9) virus, Guangzhou, China.Kinetics of Serologic Responses to MERS Coronavirus Infection in Humans, South Korea.A Predictive Risk Model for A(H7N9) Human Infections Based on Spatial-Temporal Autocorrelation and Risk Factors: China, 2013-2014.Avian Influenza A(H7N9) Virus Infection in 2 Travelers Returning from China to Canada, January 2015.Immune Repertoire Diversity Correlated with Mortality in Avian Influenza A (H7N9) Virus Infected Patients.An avian influenza H7 DNA priming vaccine is safe and immunogenic in a randomized phase I clinical trial.Kinetics of serological responses in critically ill patients hospitalized with influenza A(H1N1)pdm09 virus infection in Canada, 2009-2011.Influenza A(H7N9) Virus Antibody Responses in Survivors 1 Year after Infection, China, 2017.Impacts of age and gender at the risk of underlying medical conditions and death in patients with avian influenza A (H7N9): a meta-analysis study
P2860
Q28602120-DAADC7B1-7E2B-4DF0-9DD6-B271A4F5AF71Q30394260-9CF37107-9631-4E36-B6E2-BA45C1F90277Q33877811-96DCAB3C-CBCD-4A50-9679-37547C6FFD6EQ34137806-213E8CAD-7E8E-4EB5-A21B-1DA8C462C9B1Q35130199-E3000D9B-451E-426D-BFB2-FE5D95CCCD86Q35775376-0EE623F6-9DAD-4084-A3D6-CDF82036E077Q36183270-1638DD0F-B74A-444F-8EAF-52E4F52CC594Q36353976-BF16B806-FB74-4A7C-A5F8-D9D315CE2412Q36403586-709187E8-20E9-47B5-8509-03904850703CQ36418192-9075B1C8-4639-4C71-A66C-ECE6894C5CC4Q37285355-D758A8D7-7ECD-4766-B795-0B2A0F4F5D23Q47105782-411ABA3F-AC73-4986-BF26-A61F7BD59394Q47552454-4E943B5E-DF65-449A-B066-2DC7B1FAC909Q50064174-9758A383-F84C-400B-95C0-846D29D1B3C2Q58761615-92EED5BF-B6C3-41AD-AE39-91AF51732E63
P2860
Kinetics of serological responses in influenza A(H7N9)-infected patients correlate with clinical outcome in China, 2013.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Kinetics of serological respon ...... inical outcome in China, 2013.
@en
Kinetics of serological respon ...... inical outcome in China, 2013.
@nl
type
label
Kinetics of serological respon ...... inical outcome in China, 2013.
@en
Kinetics of serological respon ...... inical outcome in China, 2013.
@nl
prefLabel
Kinetics of serological respon ...... inical outcome in China, 2013.
@en
Kinetics of serological respon ...... inical outcome in China, 2013.
@nl
P2093
P1433
P1476
Kinetics of serological respon ...... inical outcome in China, 2013.
@en
P2093
J S Peiris
P356
10.2807/1560-7917.ES2013.18.50.20657
P577
2013-12-12T00:00:00Z